Browsing Category
Pharma Industry News
4741 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Humacyte’s $60mn funding boost sparks mixed investor reaction over equity dilution
Humacyte raises $60 million in an oversubscribed direct offering as investors debate dilution risks and long-term biotech value. Read the analysis.
Oxford Biomedica (LSE: OXB) expands US manufacturing base with Durham viral vector facility buy
Find out how Oxford Biomedica’s new US viral vector facility strengthens its CDMO leadership and growth trajectory.
Lilly’s Omvoh sets a new benchmark in ulcerative colitis with four-year steroid-free remission data
Eli Lilly’s Omvoh (mirikizumab-mrkz) delivers four years of steroid-free remission in ulcerative colitis patients according to LUCENT-3 data. Discover how this sets a new benchmark for IBD therapy.
Factory shock at Clayton: Why Novo Nordisk is cutting jobs even as it expands in America’s GLP-1 boom
Find out how Novo Nordisk’s U.S. factory job cuts fit into its $4.1 billion expansion—and what it means for Wegovy, Ozempic, and GLP-1 growth in 2025.
ESSA Pharma shareholders approve XenoTherapeutics acquisition as investors weigh biotech liquidation value
ESSA securityholders back XenoTherapeutics acquisition with 99% approval—learn how this deal reshapes biotech exit models and investor sentiment.
Silo Pharma enters DeSci ecosystem with strategic stake in ResearchCoin tokens
Find out how Silo Pharma’s acquisition of ResearchCoin (RSC) signals a bold step into decentralized science and blockchain-powered biotech collaboration.
Biomea Fusion reports positive 52-week phase II results showing non-chronic icovamenib treatment benefits in type 2 diabetes
Find out how Biomea Fusion’s 52-week phase II results point to a regenerative, non-chronic path for type 2 diabetes treatment.
Leap Therapeutics raises $58.88 million in Winklevoss-led private placement to launch digital asset treasury strategy
Find out how Leap Therapeutics is blending biotech innovation with crypto finance after a $58.9 million Winklevoss-led private placement.
How Spruce Biosciences’ tralesinidase alfa could become the first disease-modifying therapy for Sanfilippo syndrome type B
Find out how Spruce Biosciences is redefining enzyme replacement therapy with its FDA-designated tralesinidase alfa for Sanfilippo syndrome type B.
Toddlers get a breakthrough eczema treatment as FDA clears Arcutis’ ZORYVE cream 0.05%
Find out how Arcutis’ FDA-approved ZORYVE 0.05% cream is reshaping the pediatric eczema market and investor confidence in 2025.